We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-7.97%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.09B
AUM Growth
-$36M
Cap. Flow
+$13.9M
Cap. Flow %
1.28%
Top 10 Hldgs %
82.84%
Holding
43
New
6
Increased
6
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
TRML
Tourmaline Bio
TRML
+$12.2M
2
WHWK
Whitehawk Therapeutics
WHWK
+$5.75M
3
GS icon
Goldman Sachs
GS
+$4.21M
4
ALLT icon
Allot
ALLT
+$3.37M
5
APP icon
Applovin
APP
+$996K

Top Sells

Rank Stock Value
1
MP icon
MP Materials
MP
+$5.28M
2
ARGX icon
argenx
ARGX
+$2.19M
3
JD icon
JD.com
JD
+$1.12M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$379K
5
BABA icon
Alibaba
BABA
+$42.8K

Sector Composition

Rank Sector Weight
1 Healthcare 65.89%
2 Financials 8.47%
3 Communication Services 6.86%
4 Materials 2.93%
5 Industrials 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$25.2B
$664M 61.12%
65,793,779
– –
GS icon
2
Goldman Sachs
GS
$313B
$40.9M 3.77%
74,926
+7,000
+10% +$4.21M
MP icon
3
MP Materials
MP
$7.35B
$31.8M 2.93%
1,304,171
-227,400
-15% -$5.28M
ECO
4
Okeanis Eco Tankers
ECO
$2.26B
$28.3M 2.61%
1,423,997
– –
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.07T
$25.5M 2.35%
47,946
– –
NNI icon
6
Nelnet
NNI
$4.79B
$25.5M 2.35%
229,665
– –
TRML
7
DELISTED
Tourmaline Bio
TRML
$22.4M 2.06%
1,473,369
+762,094
+107% +$12.2M
NXST icon
8
Nexstar Media Group
NXST
$5.6B
$21.8M 2.01%
121,587
– –
ALLT icon
9
Allot
ALLT
$374M
$21.1M 1.94%
3,687,855
+482,062
+15% +$3.37M
ATEX icon
10
Anterix
ATEX
$1.83B
$18.4M 1.7%
503,941
– –
GS icon
11
PUT
Goldman Sachs
GS
$313B
$18M 1.66%
+33,000
New +$19.9M
NYT icon
12
New York Times
NYT
$11.6B
$15.7M 1.45%
316,947
– –
SPY icon
13
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$15.1M 1.39%
+27,000
New +$15.9M
LILAK icon
14
Liberty Latin America Class C
LILAK
$1.5B
$10.9M 1%
1,924,414
– –
ARGX icon
15
argenx
ARGX
$57.4B
$7.71M 0.71%
13,030
-3,468
-21% -$2.19M
WHWK
16
Whitehawk Therapeutics
WHWK
$183M
$7.64M 0.7%
4,515,709
+2,202,007
+95% +$5.75M
SMMT icon
17
Summit Therapeutics
SMMT
$10.9B
$6.95M 0.64%
360,524
– –
NE icon
18
Noble Corp
NE
$6.9B
$4.94M 0.46%
208,634
– –
WBD icon
19
Warner Bros
WBD
$64.6B
$4.91M 0.45%
457,850
– –
BHVN icon
20
Biohaven
BHVN
$2.16B
$4.09M 0.38%
170,006
– –
IONQ icon
21
PUT
IonQ
IONQ
$12.3B
$3.53M 0.33%
+160,000
New +$5.18M
IOVA icon
22
Iovance Biotherapeutics
IOVA
$2.23B
$2.26M 0.21%
678,564
– –
SNPS icon
23
Synopsys
SNPS
$71.5B
$1.93M 0.18%
4,503
+617
+16% +$300K
INFA
24
DELISTED
Informatica
INFA
$1.58M 0.15%
90,817
– –
GTN icon
25
Gray Television
GTN
$407M
$1.26M 0.12%
291,452
– –
1
2

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q1 2025 Portfolio in Review

As of Q1 2025, QVT Financial held 43 positions worth $1.09B, down 3.2% from $1.12B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

QVT Financial's Q1 2025 filing shows 6 new, 6 increased, 3 reduced and 3 closed positions. Its largest new stake was Applovin: 2,889 shares worth $765K. The largest sale was MP Materials, an estimated $5.28M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 74% a quarter earlier, followed by Financials and Communication Services.

  • QVT Financial's largest Q1 2025 buy was Applovin: 2,889 shares worth $765K.
  • QVT Financial added most to Tourmaline Bio in Q1 2025, an estimated $12.2M increase.
  • QVT Financial's biggest Q1 2025 reduction was MP Materials, cutting an estimated $5.28M.
  • QVT Financial fully exited JD.com in Q1 2025, selling an estimated $1.12M.
  • QVT Financial's ten largest holdings make up 83% of its $1.09B portfolio in Q1 2025.
  • QVT Financial opened 6 new positions and closed 3 in Q1 2025.
  • QVT Financial's portfolio value fell 3.2% quarter-over-quarter to $1.09B.

Based on QVT Financial's 13F filing for Q1 2025, filed 15 May 2025.